Why Intellectual Property Is Often the Most Valuable Asset in a Deep-Tech Startup
For many deep-tech and biotech startups, intellectual property is not just part of the business. It is the business.
Unlike traditional companies, early-stage deep-tech ventures often have limited physical assets or revenue. Their real value lies in:
patents,
proprietary processes,
platform technologies,
specialised know-how,
scientific data,
and technical expertise.
Yet many founders do not fully understand the commercial value of their intellectual property.
This creates risk during:
fundraising,
licensing negotiations,
partnership discussions,
and equity transactions.
Undervaluing IP can result in excessive dilution and weak negotiation positions. Overvaluing it can damage investor confidence and slow funding discussions.
At Maravion, we help deep-tech companies assess the real commercial value of their technologies through:
market analysis,
techno-economic modelling,
financial modelling,
and strategic commercialisation assessments.
Understanding the value of your IP is not simply a legal or financial exercise. It is a strategic foundation for growth.
Because investors need more than exciting science. They need confidence in the commercial potential behind it.
#IntellectualProperty #IPValuation #DeepTech #Biotech #InnovationCommercialisation #StartupGrowth #BiotechInvestment #TechTransfer #Maravion #Commercialisation
Comments